1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Life Sciences Innovative Manufacturing Fund (LSIMF) – Round 2 is a grant from the UK Government that funds capital investment to strengthen the UK's life sciences manufacturing sector. The fund supports projects that expand or enhance manufacturing capacity for medicines, medical devices, and life sciences products within the UK.
Eligible applicants include private sector businesses and research-led organizations with credible manufacturing plans. The program aims to attract and retain life sciences production in the UK, bolstering resilience in the medicines supply chain and driving commercial innovation. Applicants must demonstrate clear economic impact, job creation potential, and alignment with the UK's Life Sciences Vision.
Get alerted about grants like this
Save a search for “UK Research and Innovation (UKRI)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest - GOV.UK Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest The Life Sciences Innovative Manufacturing Fund supports businesses investing in life sciences manufacturing projects in the UK.
Department for Science, Innovation and Technology and Office for Life Sciences Get emails about this page Life Sciences Innovative Manufacturing Fund (LSIMF): application guide Life Sciences Innovative Manufacturing Fund (LSIMF): privacy notice The Life Sciences Innovative Manufacturing Fund ( LSIMF ) is open and will accept Expression of Interests ( EOI ) on a rolling basis.
The government has committed up to £520 million for life sciences manufacturing, to help deliver on the government’s missions to kickstart economic growth and build an NHS fit for the future.
The LSIMF will be UK and sector wide and will provide capital grants for investments in the manufacture of: Human medicines (this includes both the manufacture of active pharmaceutical ingredients ( API ) / drug substance and finished product / drug product). Medical diagnostics – for both disease identification and monitoring. MedTech products – all types of medical devices related to human health.
This guidance includes information about LSIMF and the application process.
Last updated 5 September 2025 data-module="ga4-event-tracker" data-ga4-event='{"event_name":"select_content","type":"content history","section":"Footer"}' data-ga4-expandable> + show all updates Updates to the LSIMF privacy notice include an expanded scope of data collection and clarification on how data is collected, the purposes of processing data and the legal basis of processing.
The Life Sciences Innovative Manufacturing Fund (LSIMF) is open and will accept Expression of Interests (EOI) on a rolling basis. Life Sciences Innovative Manufacturing Fund (LSIMF): Phase 2 closed to applications. Phase 2 open to Expressions of Interest.
Phase 1 is now closed to Expressions of Interest. Submit expressions of interest for Phase 1, Wave 3 by 31 May 2022, 12 noon. Wave 2 expressions of interest date added.
Date for submitting expressions of interest to the LSIMF Phase 1 Wave 1 changed to Friday 29 April at 12 noon. Get emails about this page No this page is not useful Thank you for your feedback Report a problem with this page Do not include personal or financial information like your National Insurance number or credit card details. This field is for robots only.
Please leave blank To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab ) .
Based on current listing details, eligibility includes: UK registered organisations Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is May 29, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
UKRI Translation: Proof of Concept is a grant from UK Research and Innovation (UKRI), via AHRC and STFC, that funds research commercialisation activities to develop new products, processes, and services through venture creation, licensing, or other commercialisation routes. Awards range from £100,000 to £250,000 and are open to researchers at UK research organisations eligible for UKRI funding, including postdoctoral researchers, group heads, and fellows. International applicants and doctoral students as lead applicants are ineligible. The application deadline is May 13, 2026, with the programme opening March 4, 2026.
The Frontier AI Benchmarking Datasets Grant Programme is a grant from UK Research and Innovation (UKRI) / Innovate UK that funds the creation, curation, annotation, and exploitation of FAIR-compliant datasets and benchmarks to support AI industry growth. A total of up to £4.5 million is available. The competition is open to collaborations only; the lead applicant must be a UK-registered business or research and technology organization (RTO), and each consortium must include at least one UK-registered SME claiming grant funding. Eligible sectors include public sector, nonprofit, and private sector organizations. The application deadline is May 27, 2026.